Md.Harun Rashid

Dr. Md.Harun Rashid


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 May 2022 in Antibiotics
Verified
Journal Article
Open access
PDF file
MRMd. Mominur Rahman
Md. Mominur Rahman
MTMst. Afroza Alam Tumpa
Mst. Afroza Alam Tumpa
MZMehrukh Zehravi
Mehrukh Zehravi
MSMd. Taslim Sarker
Md. Taslim Sarker
Md. YaminMd. Yamin
Md. Yamin
SIMONA CAVALUSIMONA CAVALU
SIMONA CAVALU
Antimicrobials are a type of agent widely used to prevent various microbial infections in humans and animals. Antimicrobial resistance is a major cause of clinical antimicrobial therapy failure, and it has become a major public health concern around the world. Increasing the development of multiple antimicrobials has become available for humans and animals with no appropriate guidance. As a result, inappropriate use of antimicrobials has significantly produced antimicrobial resistance. However, an increasing number of infections such as sepsis are untreatable due to this antimicrobial resistance. In either case, life-saving drugs are rendered ineffective in most cases. The actual causes of antimicrobial resistance are complex and versatile. A lack of adequate health services, unoptimized use of antimicrobials in humans and animals, poor water and sanitation systems, wide gaps in access and research and development in healthcare technologies, and environmental pollution have vital impacts on antimicrobial resistance. This current review will highlight the natural history and basics of the development of antimicrobials, the relationship between antimicrobial use in humans and antimicrobial use in animals, the simplistic pathways, and mechanisms of antimicrobial resistance, and how to control the spread of this resistance.

28 November 2023 in Polymers
Verified
Journal Article
Open access
PDF file
MRMd.Harun Rashid
Md.Harun Rashid
MAMost. Nazmin Aktar
Most. Nazmin Aktar
MHMd. Sabbir Hossain
Md. Sabbir Hossain
NSNadia Sarkar
Nadia Sarkar
MMMk Mk
Mk Mk
Shin-ichi YusaShin-ichi Yusa
Shin-ichi Yusa
Polymeric drug delivery technology, which allows for medicinal ingredients to enter a cell more easily, has advanced considerably in recent decades. Innovative medication delivery strategies use biodegradable and bio-reducible polymers, and progress in the field has been accelerated by future possible research applications. Natural polymers utilized in polymeric drug delivery systems include arginine, chitosan, dextrin, polysaccharides, poly(glycolic acid), poly(lactic acid), and hyaluronic acid. Additionally, poly(2-hydroxyethyl methacrylate), poly(N-isopropyl acrylamide), poly(ethylenimine), dendritic polymers, biodegradable polymers, and bioabsorbable polymers as well as biomimetic and bio-related polymeric systems and drug-free macromolecular therapies have been employed in polymeric drug delivery. Different synthetic and natural biomaterials are in the clinical phase to mitigate different diseases. Drug delivery methods using natural and synthetic polymers are becoming increasingly common in the pharmaceutical industry, with biocompatible and bio-related copolymers and dendrimers having helped cure cancer as drug delivery systems. This review discusses all the above components and how, by combining synthetic and biological approaches, micro- and nano-drug delivery systems can result in revolutionary polymeric drug and gene delivery devices.

17 January 2022 in Biology
Verified
Journal Article
Open access
PDF file
MRMd. Mominur Rahman
Md. Mominur Rahman
MMMk Mk
Mk Mk
MIMohammad Touhidul Islam
Mohammad Touhidul Islam
MRMd.Harun Rashid
Md.Harun Rashid
MIMahfuzul Islam
Mahfuzul Islam
GMgomaa mostafa-hedeab
gomaa mostafa-hedeab
Neurodegenerative diseases are a global health issue with inadequate therapeutic options and an inability to restore the damaged nervous system. With advances in technology, health scientists continue to identify new approaches to the treatment of neurodegenerative diseases. Lost or injured neurons and glial cells can lead to the development of several neurological diseases, including Parkinson’s disease, stroke, and multiple sclerosis. In recent years, neurons and glial cells have successfully been generated from stem cells in the laboratory utilizing cell culture technologies, fueling efforts to develop stem cell-based transplantation therapies for human patients. When a stem cell divides, each new cell has the potential to either remain a stem cell or differentiate into a germ cell with specialized characteristics, such as muscle cells, red blood cells, or brain cells. Although several obstacles remain before stem cells can be used for clinical applications, including some potential disadvantages that must be overcome, this cellular development represents a potential pathway through which patients may eventually achieve the ability to live more normal lives. In this review, we summarize the stem cell-based therapies that have been explored for various neurological disorders, discuss the potential advantages and drawbacks of these therapies, and examine future directions for this field.

12 February 2026 in Antibiotics
Verified
Journal Article
Open access
PDF file
MRMd. Mominur Rahman
Md. Mominur Rahman
MTMst. Afroza Alam Tumpa
Mst. Afroza Alam Tumpa
MZMehrukh Zehravi
Mehrukh Zehravi
MSMd. Taslim Sarker
Md. Taslim Sarker
Md. YaminMd. Yamin
Md. Yamin
SIMONA CAVALUSIMONA CAVALU
SIMONA CAVALU
The journal retracts the article “An Overview of Antimicrobial Stewardship Optimization: The Use of Antibiotics in Humans and Animals to Prevent Resistance”